Currently melanoma is the deadliest form of skin cancer and one of the most common cancers in women under 40 years old in the United States. The first line of defense in helping to reduce the risk of developing melanoma is by wearing broad spectrum UVA and UVB SPF protection. L’Oréal Paris, a leading global beauty brand, and Melanoma Research Alliance (MRA), the leading private funder of melanoma research, announced today the launch of It’s THAT Worth It To Me. This social media campaign encourages women to donate 15 social media seconds by sharing why SPF protection or using sunless tanner is worth it to protect their skin, their beauty and their life. For every social share, L’Oréal Paris will donate $1 to MRA to fund the L’Oréal Paris - MRA Team Science Award Research Grant, up to $250,000 in 2015.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7459051-l-oreal-paris-mra-it-s-that-worth-it/
INRIX®, Inc., a global leader for transportation analytics, today released its 2015 Traffic Scorecard, a benchmark for governments and agencies in the U.S. and Europe to measure progress in improving urban mobility.
The report reveals the U.S. faces large challenges to solve congestion issues, fueled by continued economic and population growth, higher employment rates and declining gas prices. Cities that have experienced the most economic improvement during the past year are at highest risk for consequences related to worsened traffic conditions, including reduced productivity, higher emissions and increased stress levels. For example, Washington D.C., San Francisco, New York, Seattle and Boston all saw reduced unemployment rates bringing them below the national average of 5.3 percent for 2015.1 However, according to the INRIX Traffic Scorecard, congestion in those cities alone combined to waste 1.5 billion hours for daily car commuters last year. Nationwide, commuters spent a total of more than eight billion extra hours stuck in traffic, representing almost 50 hours per driver.
To view the multimedia release go to:
http://www.multivu.com/players/English/7775551-inrix-2015-traffic-scorecard/
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and the American Diabetes Association today issued a new challenge to the millions of Americans affected by type 2 diabetes as part of the program America’s Diabetes Challenge: Get to Your Goals. In 2015, award-winning artist Tim McGraw, celebrated actress S. Epatha Merkerson and chef Leticia Moreinos Schwartz each shared their personal connection to type 2 diabetes. This year, they’re calling on people to share their stories.
Living with diabetes isn’t easy, and that’s why America’s Diabetes Challenge encourages people with type 2 diabetes to work with their doctor to set and reach their A1C goal. The program will aim to identify the most common challenges patients submit and will offer tips to help address them. The program is also designed to help people learn if they’re at risk of low blood glucose, known as hypoglycemia, and how to help reduce that risk.
To view the multimedia release go to:
http://www.multivu.com/players/English/7785551-merck-americas-diabetes-challenge/
Phenogen Sciences, Inc. today announced the availability of BREVAGenplus, an easy-to-use predictive risk test for the millions of women at risk of developing sporadic, or non-hereditary, breast cancer. The test is an enhancement of the company’s first generation product, BREVAGen®. BREVAGenplus assesses both clinical risk factors and genetic markers known to be associated with sporadic, or non-hereditary, breast cancer to determine a woman’s five-year and lifetime risk of developing the disease. The test is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans for Caucasian, Hispanic and African-American women, age 35 years or above, who have not had breast cancer, lobular carcinoma in situ (LCIS) or ductal carcinoma in situ (DCIS), and have one or more risk factors for developing breast cancer.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7337351-phenogen-sciences-introduces-brevagenplus-breast-cancer-risk-assessment-test/
Walgreens and the National Urban League announce the return of the Walgreens Wellness Tour with the National Urban League. For the ninth year, Walgreens and the National Urban League are joining together for this community outreach program dedicated to providing free preventative and early detection health services to urban and at-risk communities across the country. Now through November, Walgreens will use the tour to help provide free health tests, assessments, education and consulting services to Americans in select markets nationwide.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7511351-walgreens-wellness-tour/
The National Meningitis Association (NMA) today announced the launch of a new educational initiative in collaboration with Sanofi Pasteur, the vaccines division of Sanofi, about the importance of the Centers for Disease Control and Prevention’s (CDC’s) recommended second dose of the meningococcal meningitis vaccine (MenACWY) for adolescents at age 16. The 16 Vaccine (The16Vaccine.org) aims to educate parents about the importance of this critical second dose of MenACWY, which helps protect teens against meningococcal meningitis during the period when they are at increased risk.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385951-national-meningitis-association-the-16-vaccine/
A new Obama administration regulation–the so-called Stream Protection Rule–is about to drive up energy costs and unemployment with no gain in environmental benefits, cautions the National Mining Association.
“The primary motive of this regulation is not to protect streams, as its title would suggest, but to protect federal regulators' jobs at the expense of coal miners' jobs as the nation's energy providers,” said Luke Popovich, vice president of communications for the National Mining Association.
In a classic example of needless regulation, the U.S. Office of Surface Mining, or OSM, plans to change more than 475 regulations, as well as add more new rules – despite no demonstrated need. OSM has crafted the rule behind closed doors, Popovich said, shutting cooperating states out of discussions about the purpose and content of the regulation.
The new rule carries a heavy economic price tag, Popovich warned. He pointed to an analysis by an independent consultant that found that OSM’s rule would put more than 268,000 mining and dependent jobs at risk—adding to the 40,000 high-wage jobs already lost in the industry.
To view the multimedia release go to:
http://www.multivu.com/players/English/7221731-national-mining-association-americans-electricity-bill-increase-due-to-epa-regulations/
Willing to #migrate your online business from #VirtueMart to #Wix and maintain the best functionality? Take time to watch our video guide that will take you through all the stages of automated replatforming.
@What Data Can You Migrate?
Cart2Cart Shopping Cart Migration Service can transfer your WooCommerce data, like Products, Orders, Coupons to the new Wix store.
Learn more here: https://www.shopping-cart-migration.com/shopping-cart-migration-options/virtuemart-to-wix-migration
Don't miss the chance to launch your risk-free Demo migration right now: https://app.shopping-cart-migration.com/#sign-up Shortly, you'll be able to enjoy the benefits of Wix and boost your online business.
Primrose Schools®, a national high-quality early education and care provider, raised more than $773,000 for local and national children’s charities in 2017, breaking its previous record by more than $53,000. More than 350 Primrose preschools across the U.S. contributed to this effort, demonstrating the company’s mission to forge a path that leads to a brighter future for all children.
Last year, more than 55,000 preschool children and their families – in addition to Primrose National Leadership Support Team members, Franchise Owners, teachers and staff – participated in a variety of fundraising efforts throughout the year. These initiatives are part of the company’s Primrose PromiseSM corporate social responsibility program, which was founded in 2014 and represents the company’s commitment to make a difference in the lives of all children, especially those at greatest risk.
To view the multimedia release go to:
https://www.multivu.com/players/English/8014458-primrose-childrens-charity-fundraising-donations/
More than 46 million turkeys will be cooked this Thanksgiving holiday, according to the National Turkey Federation, but many families aren’t taking the specific actions needed to reduce their risk of foodborne illness. In an effort to help protect Americans from foodborne illness during the Thanksgiving season and throughout the year, the Ad Council is partnering with the U.S. Department of Agriculture (USDA)’s Food Safety and Inspection Service to launch new public service advertisements (PSAs) on behalf of their national Food Safe Families campaign.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7383451-usda-ad-council-launch-psas-help-families-protect-from-foodborne-illness-this-thanksgiving/
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today recognizes that more than one million people in the United States with drug-resistant epilepsy continue to be treated unsuccessfully with drugs, despite the proven effectiveness of non-drug treatment options. LivaNova’s VNS Therapy®, for example, is a medical device treatment specifically designed for people with drug-resistant epilepsy that is already used by more than 85,000 people around the world.
One in three people with epilepsy has the type that is not well controlled with drugs, called drug-resistant epilepsy. For those people, prescribing more medicine is usually not the most effective option. In fact, research shows that if you haven’t found seizure freedom after your first two drugs, there is a 95 percent chance that no drug or combination of drugs will result in seizure freedom.
“Despite what we know about drug-resistant epilepsy, the majority of people affected by this condition will continue to be prescribed additional medications instead of being evaluated for surgery or seen in a specialized epilepsy facility,” said Jason Richey, president of LivaNova’s U.S. Region and general manager of the Neuromodulation Business Franchise. “This treatment gap means over one million individuals in the U.S. with undertreated epilepsy remain at risk for dangerous side effects of continued seizures, including injury, depression, memory issues and death.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7966451-livanova-vns-therapy-epilepsy/
Many women don't realize aging makes heart disease likelier. To combat this problem, teams from Brookdale senior living communities nationwide are fanning out to personally alert women 65 and over to their increased risk and provide resources to fight it. The company hopes to reach 10,000 older women through “10,000 Heart to Hearts,” beginning Feb. 1.
“Cardiac disease kills more women than all cancers combined,” said Brookdale chief medical officer Kevin O'Neil, M.D., F.A.C.P. “On average, women develop heart disease 10 years later than men, with their first heart attack occurring at age 70.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7087732-brookdale-senior-living/
